|
|
News Breaks | | | | October 23, 2012 | | 07:02 EDT |  | VSTM | Verastem appoints Joanna Horobin as Chief Medical Officer
Verastem announced the appointment of Joanna Horobin, M.B., Ch.B., as Chief Medical Officer. Horobin was most recently the President of Syndax Pharmaceuticals, Inc. and has been responsible for the development and approval of multiple drugs over the course of her career. Horobin has 30 years of pharmaceutical drug development experience. As President of Syndax, Horobin designed and implemented the Phase 2 clinical development of entinostat in metastatic breast and lung cancer. | |
|
News For VSTM From The Last 14 Days Check below for free stories on VSTM the last two weeks. |
|
|
| May 14, 2013 | | 07:04 EDT | | VSTM | Verastem appoints Jack Green as CFO
 Subscribe for More Information | | | May 9, 2013 | | 07:35 EDT |  | VSTM | Verastem reports Q1 EPS (44c), consensus (43c)
| |
|
|
|
|
|
|
